Yildiz, I. Et Al. 2013. A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer. CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.72, no.2 , 437-444.

Yildiz, I., Tas, F., Kilic, L., Sen, F., Saip, P., Eralp, Y., ... Keskin, S.(2013). A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer. CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.72, no.2, 437-444.

Yildiz, Ibrahim Et Al. "A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer," CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.72, no.2, 437-444, 2013

Yildiz, Ibrahim Et Al. "A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer." CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.72, no.2, pp.437-444, 2013

Yildiz, I. Et Al. (2013) . "A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer." CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.72, no.2, pp.437-444.

@article{article, author={Ibrahim Yildiz Et Al. }, title={A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer}, journal={CANCER CHEMOTHERAPY AND PHARMACOLOGY}, year=2013, pages={437-444} }